Pernix Therapeutics Holdings Inc.

(PTX) Trade

Symbol has changed to a new ticker symbol

(PTXTQ)

By |

Profile

Pernix Therapeutics Holdings Inc is a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs. It aims at underserved therapeutic areas, such as central nervous system, including neurology, pain, and psychiatry. Its products include Treximet used to treat acute migraine; Zohydro ER with BeadTek, an extended-release opioid agonist indicated used in case of severe pain; Silenor for the treatment of insomnia characterized by difficulty with sleep maintenance, and Khedezla for major depressive disorder. Geographically all the operations are functioned though the United States, however also has a business presence in international market.

Contact Information

Website: www.pernixtx.com
Email: Matthew@lifesciadvisors.com
Main Phone: +1 800 793-2145
Address: 10 North Park Place
Address 2: Suite 201
State: NJ
City / Town: Morristown
Country: USA
Postal Code: 07960

Issuer Information

Exchange: NSD
CEO: John A. Sedor
Employees: 171
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Pernix Therapeutics Holdings Inc is a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs. It aims at underserved therapeutic areas, such as central nervous system, including neurology, pain, and psychiatry. Its products include Treximet used to treat acute migraine; Zohydro ER with BeadTek, an extended-release opioid agonist indicated used in case of severe pain; Silenor for the treatment of insomnia characterized by difficulty with sleep maintenance, and Khedezla for major depressive disorder. Geographically all the operations are functioned though the United States, however also has a business presence in international market.

Contact Information

Website: www.pernixtx.com
Email: Matthew@lifesciadvisors.com
Main Phone: +1 800 793-2145
Address: 10 North Park Place
Address 2: Suite 201
State: NJ
City / Town: Morristown
Country: USA
Postal Code: 07960

Issuer Information

Exchange: NSD
CEO: John A. Sedor
Employees: 171
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 11
Number of Buys 4 8
Number of Sells 0 3
Net Activity 30600 34696
Last 10 Buys Shares
Sanjay Patel 1,000
Barry J. Siegel 1,000
Douglas Drysdale 1,000
Sanjay Patel 1,000
Douglas Drysdale 1,000
Jan H. Loeb 1,000
Last 10 Sell Shares
Tracy S. Clifford 1,000
Tracy S. Clifford 1,000
Tracy S. Clifford 1,000
Tracy S. Clifford 1,000
James E. Smith 1,000
James E. Smith 1,000
James E. Smith 1,000
James E. Smith 1,000
James E. Smith 1,000
James E. Smith 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3 3 3 3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 07/11/16 07/11/16 07/11/16 07/11/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3